Stew Peters Show to Expose and Challenge the Deadly Impacts of Remdesivir
11/25/2023 Shows ↗ (Jump To Original Content)
The guests on the show, including legal professionals and medical experts, are passionate about exposing what they believe are the dangers of this drug.
They also discuss strategies to hold those responsible for promoting Remdesivir accountable, going as far as to suggest they should be charged with murder.
his episode aims to shed light on what the host and guests view as a significant and overlooked issue in the medical community, advocating for justice and accountability in healthcare.
More on Remdesivir
Pros of Remdesivir:
- Antiviral Action: Remdesivir works by inhibiting the replication of the virus, which is crucial in treating viral infections like COVID-19.
- Early Studies Showed Promise: Initial research indicated that it could reduce the recovery time for hospitalized COVID-19 patients, which was encouraging during the early stages of the pandemic.
- Emergency Use Authorization: It received emergency approval from agencies like the FDA, suggesting a level of confidence in its potential efficacy.
- Part of COVID-19 Treatment Protocols: Remdesivir became a part of the treatment protocol in many hospitals, offering an additional option for managing the disease.
- Useful in Specific Scenarios: Some studies suggest it might be more effective when used early in the course of the disease or in certain patient populations.
Cons of Remdesivir:
- Questionable Efficacy: Larger and more comprehensive studies, including the WHO's Solidarity trial, raised doubts about its effectiveness in reducing COVID-19 mortality or significantly improving patient outcomes.
- Side Effects: Patients reported adverse effects, including liver and kidney issues, which raises concerns about its safety, especially in those with pre-existing conditions.
- High Cost and Accessibility Issues: Remdesivir is expensive, which could limit its accessibility, particularly in lower-income countries or for individuals without adequate health insurance.
- Unclear Impact in Severe Cases: There's uncertainty about how much it helps in severe COVID-19 cases, as the most significant benefits seem to be in earlier stages or milder forms of the illness.
- Logistical Challenges: Administering Remdesivir requires hospitalization and intravenous infusion, which involves logistical challenges and limits its use to a hospital setting.
